Level of Macrophage uPA Expression Is an Important Determinant of Atherosclerotic Lesion Growth inApoe−/−Mice-Reference-Cited by-同舟云学术

Level of Macrophage uPA Expression Is an Important Determinant of Atherosclerotic Lesion Growth inApoe−/−Mice

Published:2009-11 Issue:11 Volume:29 Page:1737-1744
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Krishnan Ranjini¹,Kremen Michal¹,Hu Jie Hong¹,Emery Isaac¹,Farris Stephen D.¹,Slezicki Katherine I.¹,Chu Talyn¹,Du Liang¹,Dichek Helén L.¹,Dichek David A.¹

Affiliation:

1. From the Departments of Medicine (R.K., M.K., J.H.H., I.E., S.D.F., K.I.S., T.C., L.D., D.A.D.) and Pediatrics (H.L.D.), University of Washington, Seattle.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

2. Co-Localization of Fibrinolytic Activators and Inhibitors with Macrophages in Atherosclerotic Vessels

3. Relation of Urokinase-Type Plasminogen Activator Expression to Presence and Severity of Atherosclerotic Lesions in Human Coronary Arteries

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism;Journal of Thrombosis and Haemostasis;2023-10

2. Angiogenetic transcriptional profiling reveals potential targets modulated in blood of patients with cardiovascular disorders;Vascular;2021-11-24

3. PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent;Arteriosclerosis, Thrombosis, and Vascular Biology;2017-10

4. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor;Cardiovascular Research;2015-01-23

5. Renal Biopsy: Use of Biomarkers as a Tool for the Diagnosis of Focal Segmental Glomerulosclerosis;Disease Markers;2014